These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 365391)

  • 1. Effect of prazosin vs placebo on chronic left ventricular heart failure.
    Aronow WS; Lurie M; Turbow M; Whittaker K; Van Camp S; Hughes D
    Circulation; 1979 Feb; 59(2):344-50. PubMed ID: 365391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failure.
    Aronow WS; Danahy DT
    Am J Med; 1978 Jul; 65(1):155-60. PubMed ID: 356598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of prazosin in the management of chronic congestive heart failure: a 6-month randomized, double-blind, placebo-controlled study.
    Markham RV; Corbett JR; Gilmore A; Pettinger WA; Firth BG
    Am J Cardiol; 1983 May; 51(8):1346-52. PubMed ID: 6342353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the vasodilator trimazosin versus placebo on exercise performance in chronic left ventricular failure.
    Aronow WS; Greenfield RS; Alimadadian H; Danahy DT
    Am J Cardiol; 1977 Nov; 40(5):789-93. PubMed ID: 335867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term ambulatory therapy with prazosin versus placebo for chronic heart failure: relation between clinical response and left ventricular function at rest and during exercise.
    Higginbotham MB; Morris KG; Bramlet DA; Coleman RE; Cobb FR
    Am J Cardiol; 1983 Oct; 52(7):782-8. PubMed ID: 6353898
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
    Awan NA; Miller RR; DeMaria AN; Maxwell KS; Neumann A; Mason DT
    Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved exercise ejection fraction with long-term prazosin therapy in patients with heart failure.
    Goldman SA; Johnson LL; Escala E; Cannon PJ; Weiss MB
    Am J Med; 1980 Jan; 68(1):36-42. PubMed ID: 7350803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term therapy of heart failure with prazosin: a randomized double blind trial.
    Colucci WS; Wynne J; Holman BL; Braunwald E
    Am J Cardiol; 1980 Feb; 45(2):337-44. PubMed ID: 6766650
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of digitoxin versus trichlormethiazide/amiloride in congestive heart failure NYHA class II/III and sinus rhythm.
    Huonker M; Sorichter S; Schmidt-Trucksäss A; Irmer M; Staiger J; Keul J
    Cardiovasc Drugs Ther; 1999 May; 13(3):233-41. PubMed ID: 10439886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monotherapy in mild to moderate hypertension: comparison of hydrochlorothiazide, propranolol and prazosin.
    Inouye I; Massie B; Benowitz N; Simpson P; Loge D; Topic N
    Am J Cardiol; 1984 Jan; 53(3):24A-28A. PubMed ID: 6320622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT
    Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lack of symptomatic and long-term hemodynamic effects of prazosin in chronic heart failure. Double-blind, randomized study over one year].
    Reifart N; Schmidt-Moritz AD; Nadj M; Kaltenbach M; Bussmann WD
    Z Kardiol; 1985 Apr; 74(4):205-12. PubMed ID: 3923726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive therapy with prazosin in patients with left ventricular dysfunction. Improvement in cardiac performance and exercise tolerance.
    Massie BM; Chan S
    Chest; 1981 Dec; 80(6):692-7. PubMed ID: 7307590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive inotropic effects of hydralazine in human subjects: comparison with prazosin in the setting of congestive heart failure.
    Leier CV; Desch CE; Magorien RD; Triffon DW; Unverferth DV; Boudoulas H; Lewis RP
    Am J Cardiol; 1980 Dec; 46(6):1039-44. PubMed ID: 7446418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of prazosin in severe cardiac insufficiency].
    Timio M; Gentili S; Schiaroli M; Ronconi M
    G Ital Cardiol; 1979; 9(12):1371-7. PubMed ID: 549785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term therapy with oral prazosin in chronic congestive heart failure: a clinical and echocardiographic evaluation (author's transl)].
    Sparvieri F; Cesari GP; Soro A
    G Ital Cardiol; 1980; 10(6):730-40. PubMed ID: 6780400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the vasodilator prazosin and the selective beta1 agonist prenalterol on rest and exercise haemodynamics in CHF.
    Hutton I; Tweddel AC; Bastian BC; Murray RG
    Acta Med Scand Suppl; 1981; 652():163-8. PubMed ID: 6120615
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo.
    Franciosa JA; Weber KT; Levine TB; Kinasewitz GT; Janicki JS; West J; Henis MM; Cohn JN
    Am Heart J; 1982 Sep; 104(3):587-94. PubMed ID: 7051796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects at rest and during exercise in long-term treatment with prazosin in chronic congestive heart failure.
    Westheim A; Koss A; Sivertssen E
    Acta Med Scand; 1986; 219(5):449-53. PubMed ID: 3526819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of refractory congestive heart failure with prazosin.
    Awan NA; Evenson MK; Needham KE; Mason DT
    Am Heart J; 1981 Sep; 102(3 Pt 2):626-34. PubMed ID: 6267922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.